Model Answers for Pharmaceutics I Exam
Model Answers for Pharmaceutics I Exam
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 1/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 2/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
high degree of purity is required avoid such mills or Mills should be cleaned thoroughly.
8.Physiological effect: Some drugs are very potent. During their size reduction in mill,
dust is produced which may have effect on operator.
9.Ratio of feed size to product size: To get a fine powder in a mill, it is required that a
fairly small feed size should be used. Hence to carry out size reduction in various stages
e.g. preliminary crushing followed by coarse powder and then fine grinding.
10.Bulk density: The output of the size reduction of the material in a machine depends
upon the bulk density of the substance.
1 c) Define 2M
(i) Drug- A chemical agent intended for use in the diagnosis, mitigation, treatment, cure (1 X2 =
or prevention of disease in man or in other animals. 2M
(ii) Dosage forms- Dosage form is a transformation of a pure chemical compound into a
predetermined form by admixing drug components with non- drug components.
Page 3/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
1 The hard gelatin capsule shell consists The soft gelatin capsule
of two parts: Body and cap shell becomes a single unit.
2 They are cylindrical in shape They are available in
round, oval and tube-like
shapes.
3 The contents usually consist of The contents usually
medicaments in the form of powder, consist of liquids or
beads or granules semisolids.
4 These are prepared from gelatin, These are prepared from
titanium dioxide, colouring agent and gelatin, more amount
plasticizer of plasticizer (sorbitol or
glycerin) and preservative.
5 Filling and sealing takes place in Filling and sealing are
different steps. done in a combined
operation of machines
6 Shell is perfectly dry Shell is not perfectly dry
7 These capsules can be adulterated These capsules cannot be
adulterated
8 Eg: Amoxycillin Capsule Eg: Pudin Hara Capsule
1 f) Find out the proportion of procaine HCL which will yield solution iso-osmotic with 2M
0
blood plasma (FP 1% procaine HCL = -0.122 C )
Formula: %w/v of adjusting sub needed=0.52-a/b
Calculation : % w/v procaine HCLrequired = 0.52 – 000/ 0.122
= 4.26% w/v
Page 4/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 5/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 6/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
2 c) Write any three qualities of packaging material and any three disadvantages of glass 3M
as a material for packaging. (0.5 X 3)
Qualities of packaging material 1.5M
i. Neutral
ii. No interaction.
iii. Stability against environmental factor.
iv. Withstand wear and tear during handling.
v. Withstand changes in pressure and temperature.
vi. Labelled easily
vii. Non-toxic.
viii. Closure easily removable/replaceable
Disadvantages of glass
1) Glass is fragile, (0.5 X 3)
2) Glass is heavy, that can increase transportation charges, 1.5M
3) Glass containers may release alkali to aqueous preparations,
4) Flaking and weathering of glass are two serious issues related to glass.
2 d) Explain following evaluation test for tablet (any one) 3M
(i) Friability (1
Friability test is performed to evaluate ability of the tablet to with stand wear and tear in method
Packing, handling, and transporting. The apparatus used to perform this test is known as +1 result
"Friabilator". +1
The apparatus: consists of a plastic chamber, which is divided into two parts and diagram=
itrevolves at a speed of 25 rpm. Twenty tablets are weighed and placed in a 3M)
plasticchamber. The chamber is rotated for 4 minutes or 100 revolutions. During
eachrevolution the tablet falls from a distance of 6 inch. The tablets are removed from
thechamber after 100 revolutions and weighed. Loss in weight indicates the friability.
Result: The tablets are considered to be of good quality if the loss in weight is less than
0.8%.
Page 7/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
(ii) Disintegration
Disintegration of a tablet means to break a tablet into smaller particles after swallowing.
The time required to disintegrate the tablet is called disintegration time.
Method: The apparatus consists of a rigid basket-rack assembly supporting 6 cylindrical
glass tubes placed with one tablet in each tubes. The assembly should be raised and
lowered between 28 and 32 times per minute in the liquid medium at 370 C. The
assembly is suspended in the liquid medium in a 1000 ml beaker. The apparatus is
operated generally for 15 minutes and observed for disintegration of tablets.
Result: The tablets pass the test if all the tablets disintegrate. In case one or two tablets
fail to disintegrate, repeat the test on 12 additional tablets. The tablets pass the test if not
less than 16 of the total 18 tablets tested have disintegrated.
Page 8/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 9/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 10/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Hammer mill
CONSTRUCTION:
It consists of a stout metal casing enclosing to which four or more swinging hammer are
attached. The lower part of the casing consists of a screen , through which material can
pass and collected in a suitable receiver , when the desired degree of size reduction is
reached
WORKING:
The material is put in to the hopper which is connected with the drum. The material is
powdered to the desired size, due to fast rotation of hammer and is collected under the
screen. This mill has the advantage of continuous operation because of change of
jamming is less as the hammers are not fixed. The mill can produce coarse to moderately
fine powder
Page 11/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
DIAGRAM:
Page 12/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Advantages:(1M=0.5x2)
i)It can produce very fine powder
ii)It is capable of grinding wide variety of materials of differing character & of
different degree of hardness.
iii)It can be used in a completely enclosed form , which makes it especially
suitable for use with toxic materials.
iv)Can be sterilized & usedfor parenteral& ophthalmic preparations.
v)Can be used for batch as well as continuous grinding
vi)can be used for dry as well as wet grinding.
3 b) Explain construction and working of cyclone separator with a well labelled diagram. 3M,
Construction: (1M) (1
It consists of cylindrical vessel with a conical base. Construc
In upper part of vessel is fitted with a tangential inlet and fluid outlet. tion,1M
At the base it is fitted with solid outlet. working
and 1 for
Working: (1M) diagram)
In cyclone separator the centrifugal force is used to separate solids from fluids
separation depends on particle size and density of particles
The suspension of solid in gas is introduced tangentially at a very high velocity.
The rotary movement takes place within the vessels.
The fluid is removed from the outlet at the top.
The rotatory flow within the cyclone separator causes the particle to be acted on
by centrifugal force.
The solids are thrown out to the wall and fall to the conical base for discharge.
Page 13/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Diagram (1M)
Page 14/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 15/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 16/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 17/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Diagram: ( 1 mark)
Page 18/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 19/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Age
Race
Species
Individual
ACTIVE PASSIVE
IMMUNITY IMMUNITY
Natural immunity
Age : Majority of children in the age group between 2-5 years are susceptible to
diphtheria disease, whereas adults are immune to it.
Race : While the negroes have a high resistance to yellow fever, the white races
are very susceptible to it.
Species: Men are susceptible to typhoid fever, whereas mice are immune to it.
Individuals: Some persons have more resistance against cold and skin diseases
than others.
Acquired Immunity
Page 20/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 21/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
help of a powder spreader, to fill the bodies of the capsules uniformly. diagram
v) The pin plate is lowered so as to press the powder into the bodies
vi) After pressing, the pin plate is raised and the excess powder is filled into the bodies of
the capsules.
vii) The cap-holding tray is again placed in position. The sealing plate with rubber top is
lowered and the lever is operated forcing the bodies into the caps,
vii)The well-filled capsules are then cleaned by wiping with clean cloth. This gives good
shine to the capsules.
Diagram (1 M)
Page 22/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
and suspended in a suitable sterile liquid medium designed to preserve the antigenicity
and viability of the vaccine. The suspension is transferred into the final sterile containers
and freeze‐dried. Then containers are sealed so as to prevent contamination or
deterioration of the vaccine. The vaccine contains no antimicrobial agent.
Dose: Prophylactic, 0.1 ml as a single dose by intra-cutaneous injection.
Storage: Store in hermetically sealed light resistant glass containers at a temperature
between 20 C and 80 C. The reconstituted vaccine should be used immediately after its
preparation.
Uses: Immunising agent which provides protection against tuberculosis.
5 b) Give the significance of sterilization using bactericidal solution, explain the method 3M
and name the bactericidal agents. (1+1+1)
Significance:
The lethal effect of bactericide increases with the rise of temperature.
This method is used for sterilizing aqueous preparation, which is unstable at the higher
temperature, hence moist heat sterilization is not applicable method for sterilization.
It is official in British Pharmacopoeia and Indian Pharmacopoeia.
Method
In this process the medicament is dissolved or suspended in a suitable solution of
following bactericidal, as given in table, then preparation is sealed in final container and
heated at 98°-100°C for 30 minutes in boiling water.
IP 1985 permitted the use of following bactericides-
Name of Bactericides Concentration of Bactericide % w/v
For Injection:1) Chlorocresol 0.2
2) Phenyl mercuric acetate 0.002
or Phenyl mercuric nitrate
For Eye drops: 1) Chlorohexidine acetate 0.01
Page 23/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Diagram:
Page 24/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Working:
Material want to be mixed put in to hopper.
From hopper material come between roller no.1 and roller no.2 and is reduced in
size.
The gap between roller no.2 and roller no.3 is less than that between roller no.1
and roller no.2
Due to which material is crushed and gets mixed.
A Scraper is provided to remove the material from roller no.3
Diagram:
Page 25/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
5 f) How will you prepare 5 fl. 02 solutions and using that prepare a 5 litre 1 in 2000 3M
solutions?
Note: Let the student assume any data for strength of concentrated solution and
solve the problem, appropriate marks should be allotted
Data Given:
Strength of concentrated solution = 5% (assumption)
Strength of Dilute solution = 1/2000 = 0.05%
Volume of dilute solution required = 5 litre = 5000 ml
Part A: Preparation of 5% , 5 Fl.Oz solution
Amount required for preparing 1% w/v solution in imperial = 4.375 grain
Therefore, for preparing 5% w/v solution
= 4.375 X 5 X 5
= 109.37 grain.
Part B: Preparation of dilute solution.
Degree of dilution = Strength of concentrated/ Strength of Dilute solution
= 5/0.05
= 100 times.
Volume of concentrated solution required = volume of dilute solution to be prepared/
Degree of dilution
= 5000/100
= 50 ml.
Therefore, 50 ml of 5% concentrated solution is used to prepare 5 litre 1 in 2000 solution.
6 Attempt any FOUR of the followings 16M
6 a) Explain any four manufacturing defects in tablet manufacturing. 4M
i) Capping: There is partial or complete removal of top or bottom portion of the tablet. (1 X 4 =
The reasons are: Excessive fines, defective punches and dies, high speed of the machine, 4M)
too dry granules, or high degree of compaction.
ii) Picking and sticking: In picking, the material is removed or picked up by the upper
punch from the upper surface of the tablet. In sticking, the material sticks to the wall of
the die. These defects appear due to worn out dies and punches, small quantity of
Page 26/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 27/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
7) Working surface.
Test for Sterility: (1.5M)
Principle: These tests are based on the principle that if bacteria or fungi are placed in
medium provided favourable conditions like nutritive material, moisture temperature, the
organism will grow and their presence can be indicated by the turbidity in clear solution.
These test should be carried out in strictly aseptic condition.
Method of testing : Test of sterility may be carried out by
1) Membrane filtration method
2) Direct inoculation method
1) Direct inoculation method: The substance to be tested is aseptically drawn from the
container by a suitable device and transferred to the final culture medium in the test tube.
The inoculated medium (test tubes) are incubated at 20-25°C for fungi and 30-37°C for
bacteria for the period of seven days. Observe the growth of micro-organism in the
medium.
2) Membrane filtration method : This method is preferred in the following cases-
An oil or oily preparations, ointment, A non-bacteriostatic solid, soluble powder or a
liquid that possesses bacteriostatic and fungistatic properties, liquid products where
volume in a container is 100 ml or more.
Carry out filtration of sample under test through membrane filter having pore size of 0.45
µ and diameter of about 47 mm. After the filtration, the membrane is removed aseptically
from the metallic holder and divided into two halves. The first half is transferred into 100
ml of culture media meant for fungi and incubated at 20 to 25°C for not less than 7 days.
The other half is transferred into 100 ml of fluid thioglycolate medium meant for bacteria
and incubated at 30 to 35°C for not less than 7 days. Observe the growth of the media.
Results :If no growth of micro-organism is found in any of the tubes, the sample is
declared to have pass the test and same test is repeated for two times.
Page 28/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
6 c) Find the volume of 20%, 15%, 10% and 8% alcohol should be mixed to get 12% 4M
alcohol 300 ml
20 % 12-8 = 4 parts of 20 %
15 % 12-10 = 2 parts of 15 %
12 %
10 % 12-15 = 3 parts of 10 %
8% 12-20 = 8 parts of 08 %
17
= 70.58 ml
For 300 ml of 15 % alcohol = 300 x 2
17
= 35.29 ml
For 300 ml of 10 % alcohol = 300 x 3
17
= 52.94 ml
For 300 ml of 8 % alcohol = 300 x 8
17
= 141.17ml
6 d) Define mixing, explain types and mechanism of mixing. 4M
Definition of Mixing: (1M) (1+1.5+1.
Mixingis the method in which two or more than two substances are combined together. 5)
Page 29/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
Page 30/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
7) Prodrugs
8) Film and strips.
1) Implants:
The hypodermic tablets are placed under the skin by a minor surgery in order to release
drugs over a prolonged periods of time. Now the magnetically controlled implants have
been developed which can be opened or closed in order to release or stop the drug. The
implants which are in capsule form, consist of a body and a cap. It can be opened by
placing a magnet onthe skin and moving it in the desired direction. These implants are
placed in the upper thigh at a depth of 5 mm. These implants are useful in hormone
therapy
2) Controlled Drug Delivery System:
Controlled Drug Delivery Systems are devices which are formed by embedding the drug
within polymeric matrix so that it get released slowly to the body over a very long period
of time .The polymeric matrices used to hold drug reversibly are polyethylene silicon
elastomer and cellulose ester.
These controlled drug delivery modules are punctured before administration with laser
beam to make a small orifice of a few microns in diameter for the release of drug.
3) Sustained Release system:
Sustained released dosage forms are the new drug delivery system. They provide a
therapeutic blood level of the drug which is attained rapidly and is maintained within
narrow limits over extended period of a time, usually for 10 to 12 hrs. afer administration
of single dose. Sustained release of dosage are achieved because they are enteric coated
which get released in specific part of body.
4) Liposomes:
They are phospholipids which can be transported with hydrophilic and hydrophobic
drugs.
Applications:
1) Liposomal drugs are used in diseases caused by intracellular parasites.
e. g. Malaria, Tuberculosis
2) Liposomes can be used to transport functional DNA/RNA molecules into cells.
Page 31/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
5) Erythrocytes:
As the life span of Erythrocytes is 120 days drugs are encapsulated in Erythrocytes. The
drug release for a prolonged period of time.
Applications:
1) Resealed erythrocytes of asparaginase have shown good results in asparaginase
dependant leukaemia.
2) Resealed erythrocytes of methotrexate and adrianycin have been tried in cancer
therapy.
6) Nanoparticles:
The particle size ranges from 200-500 nm. The system consists of drug and carrier to
deposit the drug at the target site. The carrier used are serum albumin, bovine serum,
albumin, gelatin, casein, s ethyl cellulose.
7) Prodrugs:
The compounds that shows desirable pharmacological activity after its metabolism are
called as prodrugs. Prodrugs are used to increase solubility, stability and bioavailability
of drug, masking the unpleasant taste and odour of the parent drug and reducing the
toxicity.
8) Film and strips:
These are meant for topical application for slow release of drug over predetermined
period of time. The film and strips which are becoming popular these days are
I. Zero order release film.
II. Buccal Stip.
III. Spray bandages.
Page 32/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
6 f) Explain the method of hot percolation process with well labelled diagram and write 4M
its limitations. (1.5 +1.5
Diagram: (1.5M) + 1)
Procedure : (1.5M)
1) The menstrum is placed in a round bottom flask.
2) The drug to be extracted is packed in a filter paper and placed in the body of Soxhlet
extractor.
3) Solvent is boiled on heating a flask.
4) The vapour enter into the condenser through the side tube. The vapour get condensed
into hot liquid, which falls on the column of drug.
5) The extractor gets filled with the solvent. Hot solvent extracts the active constituents
of the drug.
6) The solvent having active constituents syphon over and run into the flask through the
syphon tube.
7) The alternate process of filling and emptying the body of extractor goes on
Page 33/34
MAHARASHTRA STATE BOARD OF TECHNICAL EDUCATION
(Autonomous)
(ISO/IEC - 27001 - 2005 Certified)
MODEL ANSWER
SUMMER– 19 EXAMINATION
Subject Title: PHARMACEUTICS-l Subject Code: 0805
__________________________________________________________________________________________________
continuously.
8) The soluble active constituents of the drug remain in the flask, while the solvent
evaporates respectively.
9) This process continues till drug exhausted.
10) Normally the process is repeated about 15 times to exhaust the drug properly.
Limitation : (0.5 X 2=1)
1. Physical character of the drug: If the drug would block the soxhlet apparatus then this
process cannot be used for extraction. Eg opium. Gum, resin, orange peel, etc.
2. Solvent: Only pure solvents or constant boiling mixtures can be used.
3. Chemical constituents of the drug: The process is unsuitable for drugs having
thermolabile active constituents such as enzymes, alkaloids, anthraquinone derivatives,
esters, etc.
Page 34/34